(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KLICKMER

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

KLICKMER

ST13

US500000079311991

Class

1, 5

Filing

79311991

Registration

6720843

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

11/19/2024

Trademark type

Word

Nice classes

1, 5

Filing date

02/05/2021

Registration date

05/24/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/24/2022

Last transaction

11/19/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

16

Owner location

DK

Examiner

VERHOSEK, WILLIAM

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

I. A. (pessoa física)

Representatives

Miriam D. Trudell Davis Graham & Stubbs LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicals used in diagnosticsindustry and scienceother than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagentsmonoclonal antibodiesreagentsdiagnostic agentscontrol reagentsDNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapycancer vaccinesborrelia vaccinesTB-vaccinesHIV-vaccinesCMV-vaccines and other vaccinesfor analysis for research purposes of T-cell lymphomaT-cell infiltration of solid tumors and tissuefor analysis for research purposes of infectious diseasesautoimmunity and for use in connection with toxicological studies and research in relation to transplantationimmune monitoringvaccines and T-cell monitoring; chemical reagents other than for medicinal and veterinary purposes

Class 5

Preparations for pharmaceutical purposes for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccinesimmunotherapeutics and cellular therapiesincluding cancer vaccines and immunotherapeuticsborrelia vaccinesTB-vaccinesHIV-vaccines and CMV-vaccinesT-cell therapiesfor use in connection with cancer therapy and other medical therapiesfor analysis and treatment of T-cell lymphomaT-cell infiltration of solid tumors and tissuefor infectious diseasesfor use in connection with medical procedures and diagnosistransplantationimmune monitoringvaccines and T-cell monitoring

Publications

History of USPTO decisions and trademark events.

35 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/12/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/12/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/12/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/14/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/14/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

04/14/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/14/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/14/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/14/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/02/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/03/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/09/2022

FIMP

FINAL DISPOSITION PROCESSED

09/09/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/24/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/24/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

05/24/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/22/2022

PUBO

PUBLISHED FOR OPPOSITION

02/22/2022

GPNX

NOTIFICATION PROCESSED BY IB

02/20/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/02/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/02/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/02/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/20/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/13/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/13/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/13/2022

RFNT

REFUSAL PROCESSED BY IB

10/04/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/13/2021

RFRR

REFUSAL PROCESSED BY MPU

09/13/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/01/2021

CNRT

NON-FINAL ACTION WRITTEN

08/31/2021

DOCK

ASSIGNED TO EXAMINER

08/30/2021

MAFR

APPLICATION FILING RECEIPT MAILED

06/08/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/02/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/27/2021

Continuous trademark protection

Get notified about every new filing that threatens KLICKMER or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.